Navigation Links
Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
Date:2/12/2008

IRVINE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today that it has filed a patent infringement lawsuit against CoreValve, Inc., of Irvine, Calif., in the United States District Court for the District of Delaware. The suit seeks injunctive relief and damages for infringement of three of the Andersen family of patents for transcatheter heart valve technology.

"Edwards has a significant portfolio of patents in transcatheter heart valve technology, led by the Andersen patent family, and we are committed to protecting this valuable intellectual property and the interests of our clinician-inventors," said Bruce P. Garren, Edwards' corporate vice president and general counsel.

In May 2007, Edwards initiated litigation against CoreValve in the District Court of Dusseldorf, Germany, for infringement of a related Andersen patent, EP 0 592 410 B1, and similar litigation is also now pending in the United Kingdom. The European litigations address the sale of CoreValve's infringing valves; the suit filed today is directed at CoreValve's manufacture of valves in the United States for export and sale in Europe.

The relevant U.S. patents, No. 5,411,552, No. 6,168,614 and No. 6,582,462 -- part of the Andersen patent portfolio -- are fully owned by Edwards. These patents relate to a valve prosthesis for implantation by means of a catheter, and the product named in the suit is the CoreValve ReValving System.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Edwards Lifesciences Reports Strong Fourth Quarter Sales
2. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
3. Edwards Lifesciences to Present at the Southern California Investor Conference
4. Edwards Lifesciences Announces Schedule of Activities at TCT 2007
5. Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007
6. Elizabeth Edwards to Join SEIU Activists at Conference
7. Exciting New Plan from John Edwards on AIDS; Plan is Bold and Achievable, say New Hampshire Activists
8. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
9. Edwards Plan on AIDS Unveiled Today
10. Spectranetics to Present at The A.G Edwards Growth Conference on September 18
11. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: